Swiss National Bank Protagonist Therapeutics, Inc Transaction History

Swiss National Bank

$143 Billion
Q2 2024

A detailed history of Swiss National Bank transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Swiss National Bank holds 85,900 shares of PTGX stock, worth $4.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

85,900

Previous 90,700 5.29%

Holding current value

$4.09 Million

Previous $2.62 Million 13.46%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$24.66 - $34.8 $118,368 - $167,040	-4,800 Reduced 5.29%	85,900 $2.98 Million
Q4 2023 Feb 06, 2024	SELL	$14.05 - $23.44 $139,095 - $232,056	-9,900 Reduced 9.84%	90,700 $2.08 Million
Q3 2023 Nov 08, 2023	BUY	$16.68 - $23.66 $43,368 - $61,516	2,600 Added 2.65%	100,600 $1.68 Million
Q2 2023 Aug 09, 2023	BUY	$18.02 - $29.36 $329,766 - $537,288	18,300 Added 22.96%	98,000 $2.71 Million
Q1 2023 May 10, 2023	SELL	$10.78 - $25.38 $99,176 - $233,496	-9,200 Reduced 10.35%	79,700 $1.83 Million
Q4 2022 Feb 08, 2023	BUY	$7.36 - $11.17 $17,664 - $26,808	2,400 Added 2.77%	88,900 $969,000
Q3 2022 Nov 09, 2022	BUY	$7.86 - $11.71 $17,292 - $25,762	2,200 Added 2.61%	86,500 $729,000
Q2 2022 Aug 09, 2022	SELL	$7.06 - $25.52 $121,432 - $438,944	-17,200 Reduced 16.95%	84,300 $667,000
Q1 2022 May 09, 2022	BUY	$23.34 - $36.08 $170,382 - $263,384	7,300 Added 7.75%	101,500 $2.4 Million
Q4 2021 Feb 08, 2022	BUY	$17.63 - $37.1 $119,884 - $252,280	6,800 Added 7.78%	94,200 $3.22 Million
Q3 2021 Nov 08, 2021	BUY	$12.95 - $49.69 $7,770 - $29,814	600 Added 0.69%	87,400 $1.55 Million
Q2 2021 Aug 06, 2021	BUY	$25.57 - $44.88 $81,824 - $143,616	3,200 Added 3.83%	86,800 $3.9 Million
Q1 2021 May 07, 2021	BUY	$19.02 - $31.15 $17,118 - $28,035	900 Added 1.09%	83,600 $2.17 Million
Q4 2020 Feb 05, 2021	BUY	$18.49 - $25.13 $1.53 Million - $2.08 Million	82,700 New	82,700 $1.67 Million

Others Institutions Holding PTGX

# of Institutions

212

Shares Held

59.1M

Call Options Held

19K

Put Options Held

107K

View Full List

About Protagonist Therapeutics, Inc

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.34B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

More about PTGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Protagonist Therapeutics, Inc Transaction History